DIAPH3 can promote tumorigenesis of hepatocellular carcinoma, pancreatic cancer, and lung adenocarcinoma [11, 16, 17], while suppressing the tumorigenesis of triple-negative breast cancer [15]. Here, DIAPH3 is linked to pancreatic neoplasm.